ConvaTec Aktie
| 2,46EUR | -0,02EUR | -0,81% |
WKN DE: A2AUD3 / ISIN: GB00BD3VFW73
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 10 142 | 10 036 | 10 136 | 10 489 | 10 910 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,15 | 0,17 | 0,17 | 0,17 | 0,17 |
Bilanz (in Mio. GBP) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 820 | 739 | 682 | 633 | 699 |
| Summe Anlagevermögen | 1 892 | 2 247 | 2 231 | 2 173 | 2 112 |
| Summe Aktiva | 2 713 | 2 986 | 2 913 | 2 807 | 2 811 |
Bilanz (in Mio. GBP) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 461 | 1 648 | 1 585 | 1 458 | 1 682 |
| Summe Eigenkapital | 1 251 | 1 338 | 1 328 | 1 349 | 1 129 |
| Summe Passiva | 2 713 | 2 986 | 2 913 | 2 807 | 2 811 |
Adresse
| 20 Eastbourne Terrace, W2 6LG London | |
| Telefon | +44 (11) 89528100 |
| Internet | http://www.convatecgroup.com |
Management
|
Brian Michael May
Independent Non-Executive Director |
|
Clare Holden
Chief Quality & Regulatory Affairs Officer |
|
David Phillips
Treasury & Head-Investor Relations |
|
David Shepherd
Chief Commercial Officer |
|
Emma Rose
Chief People Officer & Executive Vice President |
|
Evelyn Douglas
Chief Strategy & Business Development Officer |
|
Fiona Victoria Ryder
CFO, Director & Financial Controller |
|
Heather Lynn Mason
Independent Non-Executive Director |
|
James Edward Spencer Kerton
Secretary, General Counsel & Executive VP |
|
John David Gibson McAdam
Chairman |
|
Jonathan Peter Mason
Chief Executive Officer & Director |
|
Kimberly Sue Lody
Independent Non-Executive Director |
|
Kjersti Grimsrud
President-Infusion Care |
|
Margaret Ewing
Senior Independent Non-Executive Director |
|
Neal Carty
Chief Science & Innovation Officer |
|
Peter Jarvis
Chief Operations Officer |
|
Sharon L. O'Keefe
Independent Non-Executive Director |